Accelerate Diagnostics
Diagnostics firm offering automated antibiotic susceptibility results from blood cultures via Accelerate Pheno™ System.
Founded
2004Diagnostics firm offering automated antibiotic susceptibility results from blood cultures via Accelerate Pheno™ System.
Accelerate Diagnostics is a diagnostics firm dedicated to improving patient outcomes and combating antimicrobial resistance through innovative technology. Their core product, the Accelerate Pheno™ System, provides fully automated antibiotic susceptibility results directly from positive blood cultures. This system aids healthcare providers in making timely and accurate treatment decisions for patients with serious infections. The company focuses on clinical microbiology, addressing challenges in rapid diagnostics and effective treatment.
Accelerate Diagnostics has made significant strides in the field of clinical microbiology, with numerous publications and patient case studies highlighting their impact. Their collaboration with BD aims to enhance patient care and slow the spread of antimicrobial resistance. The company offers comprehensive support, including technical assistance and product orders, ensuring seamless integration of their solutions in healthcare settings.
Companies similar to Accelerate Diagnostics include Specific Diagnostics, Acenxion Biosystems, Selux Diagnostics and BioAmp diagnostics.
Accelerate Diagnostics was founded in 2004.
Accelerate Diagnostics' headquarters is located in Tucson, AZ, US.
Accelerate Diagnostics' most recent funding round was for $15M (USD) in January 2024.
As of Jan 19, 2024, Accelerate Diagnostics has disclosed funding of $264.1M (USD). Undisclosed round amounts are excluded.
Accelerate Diagnostics has 179 employees as of Feb 6, 2024.
BioAmp diagnostics
bioampdx.com
